Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Meridien Research
mi
from
Brooksville, FL
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Meridien Research
mi
from
Brooksville, FL
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Brain Matters Research
mi
from
Delray Beach, FL
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Brain Matters Research
mi
from
Delray Beach, FL
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
MD Clinical
mi
from
Hallandale Beach, FL
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
MD Clinical
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Compass Research LLC
mi
from
Orlando, FL
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Miami Research Associates
mi
from
South Miami, FL
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
USF Suncoast Alzheimer's and Gerontology Center
mi
from
Tampa, FL
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
USF Suncoast Alzheimer's and Gerontology Center
mi
from
Tampa, FL
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Center for Clinical Trials, LLC
mi
from
Venice, FL
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Center for Clinical Trials, LLC
mi
from
Venice, FL
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Indiana University Medical Center
mi
from
Indianapolis, IN
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Indiana University Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Four Rivers Clinical Research
mi
from
Paducah, KY
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Four Rivers Clinical Research
mi
from
Paducah, KY
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Memory Enhancement Center Of Amercia, Inc.
mi
from
Eatontown, NJ
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Memory Enhancement Center Of Amercia, Inc.
mi
from
Eatontown, NJ
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Global Medical Institutes, Llc
mi
from
Princeton, NJ
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Global Medical Institutes, Llc
mi
from
Princeton, NJ
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Columbia University
mi
from
New York, NY
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
University of Rochester
mi
from
Rochester, NY
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Richard H. Weisler & Associates
mi
from
Raleigh, NC
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Richard H. Weisler & Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Ohio State University
mi
from
Columbus, OH
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Neurology & Neuroscience Center of Ohio
mi
from
Toledo, OH
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Neurology & Neuroscience Center of Ohio
mi
from
Toledo, OH
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Tulsa Clinical Research
mi
from
Tulsa, OK
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Tulsa Clinical Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Professional Neurological Associates, Pc
mi
from
Dunmore, PA
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Professional Neurological Associates, Pc
mi
from
Dunmore, PA
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
The Clinical Trial Center, LLC
mi
from
Jenkintown, PA
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
The Clinical Trial Center, LLC
mi
from
Jenkintown, PA
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
R.I. Mood & Memory Research Institute
mi
from
East Providence, RI
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
R.I. Mood & Memory Research Institute
mi
from
East Providence, RI
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Butler Hospital
mi
from
Providence, RI
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Butler Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
University of Texas
mi
from
Dallas, TX
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
University of Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Dean Foundation For Health Research & Education
mi
from
Middleton, WI
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Dean Foundation For Health Research & Education
mi
from
Middleton, WI
Click here to add this to my saved trials
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  9/23/2015
Local Institution
mi
from
Odense,
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 9/23/2015
Local Institution
mi
from
Odense,
Click here to add this to my saved trials
Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.
A Double-Blind, Placebo-Controlled Single Dose Study of the Safety and Efficacy of Glulisine on Cognitive Function and Memory in Individuals Diagnosed With Probable Mild to Moderate Alzheimer's Disease/Intranasal Insulin Study.
Status: Enrolling
Updated:  9/25/2015
HealthPartners Specialty Center - Center for Dementia & Alzheimer's Care
mi
from
St. Paul, MN
Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.
A Double-Blind, Placebo-Controlled Single Dose Study of the Safety and Efficacy of Glulisine on Cognitive Function and Memory in Individuals Diagnosed With Probable Mild to Moderate Alzheimer's Disease/Intranasal Insulin Study.
Status: Enrolling
Updated: 9/25/2015
HealthPartners Specialty Center - Center for Dementia & Alzheimer's Care
mi
from
St. Paul, MN
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
Hospice of the Valley MediCaring Project
mi
from
Phoenix, AZ
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
Hospice of the Valley MediCaring Project
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
Georgetown University Medical Center-Mind My Heart Program
mi
from
Washington,
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
Georgetown University Medical Center-Mind My Heart Program
mi
from
Washington,
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
Quality Oncology/Matria Healthcare
mi
from
Sunrise, FL
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
Quality Oncology/Matria Healthcare
mi
from
Sunrise, FL
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
CorSolutions/Matria Healthcare
mi
from
Rosemont, IL
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
CorSolutions/Matria Healthcare
mi
from
Rosemont, IL
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
Carle Foundation Hospital
mi
from
Urbana, IL
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
Carle Foundation Hospital
mi
from
Urbana, IL
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
Mercy Medical Center - North Iowa
mi
from
Mason City, IA
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
Mercy Medical Center - North Iowa
mi
from
Mason City, IA
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
Medical Care Development
mi
from
Augusta, ME
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
Medical Care Development
mi
from
Augusta, ME
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
University of Maryland Medical Center
mi
from
Baltimore, MD
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
Charlestown/Erickson Retirement Communities
mi
from
Catonsville, MD
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
Charlestown/Erickson Retirement Communities
mi
from
Catonsville, MD
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
Washington University-St.Louis School of Medicine/Barnes-Jewish Hospital
mi
from
St. Louis, MO
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
Washington University-St.Louis School of Medicine/Barnes-Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
QMed, Inc.
mi
from
Eatontown, NJ
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
QMed, Inc.
mi
from
Eatontown, NJ
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
Lovelace Health Systems
mi
from
Albuquerque, NM
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
Lovelace Health Systems
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
Jewish Home Lifecare
mi
from
New York, NY
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
Jewish Home Lifecare
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
Avera McKennan Hospital and University Health Center
mi
from
Sioux Falls, SD
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
Avera McKennan Hospital and University Health Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
CenVaNet
mi
from
Richmond, VA
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
CenVaNet
mi
from
Richmond, VA
Click here to add this to my saved trials
Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin Memory Research Program
mi
from
Madison, WI
Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin Memory Research Program
mi
from
Madison, WI
Click here to add this to my saved trials
Alzheimer's Disease: Potential Benefit of Isoflavones
Alzheimer's Disease: Potential Benefit of Isoflavones
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin
mi
from
Madison, WI
Alzheimer's Disease: Potential Benefit of Isoflavones
Alzheimer's Disease: Potential Benefit of Isoflavones
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease
Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin - Wisconsin Comprehensive Memory Program
mi
from
Madison, WI
Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease
Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin - Wisconsin Comprehensive Memory Program
mi
from
Madison, WI
Click here to add this to my saved trials
fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease
fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin - Wisconsin Comprehensive Memory Program
mi
from
Madison, WI
fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease
fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin - Wisconsin Comprehensive Memory Program
mi
from
Madison, WI
Click here to add this to my saved trials
PET Imaging of Brain Amyloid Using [11C]MeS-IMPY
PET Imaging of Brain Amyloid Using [11C]MeS-IMPY
Status: Enrolling
Updated:  10/5/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
PET Imaging of Brain Amyloid Using [11C]MeS-IMPY
PET Imaging of Brain Amyloid Using [11C]MeS-IMPY
Status: Enrolling
Updated: 10/5/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 24-Week, Phase 2 Study of Two Doses of EVP-6124 Hydrochloride or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently Receiving Memantine Medication With or Without Additional Acetylcholinesterase Inhibitor Co-Medication
Status: Enrolling
Updated:  10/13/2015
Clinical Research Facility
mi
from
Delray Beach, FL
Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 24-Week, Phase 2 Study of Two Doses of EVP-6124 Hydrochloride or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently Receiving Memantine Medication With or Without Additional Acetylcholinesterase Inhibitor Co-Medication
Status: Enrolling
Updated: 10/13/2015
Clinical Research Facility
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 24-Week, Phase 2 Study of Two Doses of EVP-6124 Hydrochloride or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently Receiving Memantine Medication With or Without Additional Acetylcholinesterase Inhibitor Co-Medication
Status: Enrolling
Updated:  10/13/2015
Clinical Research Facility
mi
from
Albuquerque, NM
Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 24-Week, Phase 2 Study of Two Doses of EVP-6124 Hydrochloride or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently Receiving Memantine Medication With or Without Additional Acetylcholinesterase Inhibitor Co-Medication
Status: Enrolling
Updated: 10/13/2015
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program
Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program
Status: Enrolling
Updated:  10/18/2015
Emory Alzheimer's Disease Research Center
mi
from
Atlanta, GA
Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program
Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program
Status: Enrolling
Updated: 10/18/2015
Emory Alzheimer's Disease Research Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
Status: Enrolling
Updated:  10/19/2015
VA Medical Center, Omaha
mi
from
Omaha, NE
Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
Status: Enrolling
Updated: 10/19/2015
VA Medical Center, Omaha
mi
from
Omaha, NE
Click here to add this to my saved trials
ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease
A Twelve Month Double-blind Randomized Controlled Feasibility Study to Evaluate the Safety, Efficacy and Tolerability of Deep Brain Stimulation of the Fornix (DBS-f) in Patients With Mild Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/27/2015
Banner Alzheimer'S Institute
mi
from
Phoenix, AZ
ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease
A Twelve Month Double-blind Randomized Controlled Feasibility Study to Evaluate the Safety, Efficacy and Tolerability of Deep Brain Stimulation of the Fornix (DBS-f) in Patients With Mild Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/27/2015
Banner Alzheimer'S Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials